Multiple human papillomavirus genotype infections in cervical cancer progression in the study to understand cervical cancer early endpoints and determinants.
about
Human papillomavirus genotype-specific prevalence across the continuum of cervical neoplasia and cancer.No evidence for synergy between human papillomavirus genotypes for the risk of high-grade squamous intraepithelial lesions in a large population-based study.Individual detection of 14 high risk human papilloma virus genotypes by the PapType test for the prediction of high grade cervical lesions.Human papillomavirus type 16 viral load measurement as a predictor of infection clearance.Human papillomavirus genotype distribution in Czech women and men with diseases etiologically linked to HPVHuman papillomavirus prevalence among indigenous and non-indigenous Australian women prior to a national HPV vaccination programCervical histopathology variability among laboratories: a population-based statewide investigationClinical and pathological heterogeneity of cervical intraepithelial neoplasia grade 3.Molecular mapping of high-grade cervical intraepithelial neoplasia shows etiological dominance of HPV16.Lineages of oncogenic human papillomavirus types other than type 16 and 18 and risk for cervical intraepithelial neoplasia.Hierarchical clustering of human papilloma virus genotype patterns in the ASCUS-LSIL triage studyThe role of co-factors in the progression from human papillomavirus infection to cervical cancerHPV genotype distribution in cervical intraepithelial neoplasia among HIV-infected women in Pune, India.Oral human papillomavirus in men having sex with men: risk-factors and sampling.HPV genotypes and associated cervical cytological abnormalities in women from the Pearl River Delta region of Guangdong province, China: a cross-sectional study.Concurrence of multiple human papillomavirus infections in a large US population-based cohort.Multiple biopsies and detection of cervical cancer precursors at colposcopy.Human papillomavirus infection with multiple types: pattern of coinfection and risk of cervical disease.High HPV-51 prevalence in invasive cervical cancers: results of a pre-immunization survey in North Sardinia, Italy.Persistence of concurrent infections with multiple human papillomavirus types: a population-based cohort study.Early natural history of incident, type-specific human papillomavirus infections in newly sexually active young women.A study of genotyping for management of human papillomavirus-positive, cytology-negative cervical screening resultsInvited commentary: multiple human papillomavirus infections and type replacement-anticipating the future after human papillomavirus vaccination.High prevalence of hpv multiple genotypes in women with persistent chlamydia trachomatis infection.Human papillomavirus type-specific prevalence in the cervical cancer screening population of Czech women.Human papillomavirus (HPV) genotypes in women with cervical precancer and cancer at Kaiser Permanente Northern California.A long-term prospective study of type-specific human papillomavirus infection and risk of cervical neoplasia among 20,000 women in the Portland Kaiser Cohort Study.Potential impact of a nonavalent HPV vaccine on the occurrence of HPV-related diseases in France.HPV-type distribution and reproducibility of histological diagnosis in cervical neoplasia in Poland.Laser capture microdissection as a tool to evaluate human papillomavirus genotyping and methylation as biomarkers of persistence and progression of anal lesionsDetection of HPV DNA in paraffin-embedded cervical samples: a comparison of four genotyping methodsChromosomal copy number alterations and HPV integration in cervical precancer and invasive cancerDetection of Human Papillomavirus Infections at the Single-Cell Level.Human papillomavirus load measured by Linear Array correlates with quantitative PCR in cervical cytology specimensHeterogeneity of high-grade cervical intraepithelial neoplasia related to HPV16: implications for natural history and management.Assessment of human papillomavirus E6/E7 oncogene expression as cervical disease biomarker.Prevalence and risk factors for oncogenic human papillomavirus infections in high-risk mid-adult women.A Suggested Approach to Simplify and Improve Cervical Screening in the United States.Human papillomavirus genotype attribution and estimation of preventable fraction of anal intraepithelial neoplasia cases among HIV-infected men who have sex with menA comparison of human papillomavirus genotype-specific DNA and E6/E7 mRNA detection to identify anal precancer among HIV-infected men who have sex with men.
P2860
Q30301333-587CE170-5A16-4BC8-94B4-5E28B85E0740Q30407482-ADDB9ECE-3A00-4399-99DE-331323C4EB23Q33574454-9EA9F852-FEBA-4CF5-A22A-4DB11D6B53ECQ33887322-80DCCF7E-972D-493C-816E-91B796A3F8ABQ33963857-7F411B19-DDBF-47CB-9034-B500D9B6DA56Q34017208-329B9652-1454-4B2E-9186-7FA69F5C9EB3Q34017556-0E9F6818-B6B9-4A99-AB39-751824CB4A72Q34130333-2E86789D-BD11-4025-8DCE-1F4C1F16782AQ34196510-9516410A-F91F-4944-8B16-9F46D915FF9EQ34209101-66495CE4-5579-4C63-8289-A48D96D76689Q34268415-998C52B3-BE6D-4573-A387-9F012ACB1C48Q34311313-8C2B4D91-A97E-45F9-B074-33D4C53DB64DQ34313933-FBBA0BFD-1B5A-41D6-B73A-A64AFFCBF068Q34485222-C5601189-80E5-4836-8D73-2145499BC33EQ34485433-A919C651-A206-413B-BA26-2845D2628A28Q34553582-1A636DA7-5415-46A8-8012-D5564EFC78CDQ34716608-9D71BC4B-E146-4392-950E-9BA80CE82687Q34743370-9318650C-B5D1-4364-8F39-35569BEE1284Q34744071-D14A6294-14CE-4318-90C6-B86E7E2C6765Q34764058-D4E11634-4F74-49A4-8E15-81F7F71400DDQ34807534-1A48B158-39D2-4EE3-A443-B6FB4FA0AB9DQ34916671-C7A568EF-0B8C-4277-BA62-3CECE5115718Q34974475-6CEEAFA5-ABE0-40D4-B56C-04A61AC040A2Q35004783-96F222E2-0FB0-4F65-AAA7-48F0E5D6FAE5Q35050431-B9ED8657-7A4F-431A-A13B-7122F11F6BC9Q35051454-328D64AE-B714-49BB-A8C7-150B7B635205Q35164373-7E6C9CD7-48E4-4405-BC60-E56F5466C2EBQ35610248-41EA69BB-6EC7-44DC-B1A4-88593447FDABQ35675350-7AF812B1-E56D-4B83-A6C1-51ADB44BDF89Q35756579-D86BC5BA-D4C1-4970-83D6-F081B6BEA6CCQ35852900-24538B0F-0CED-4473-81D2-6F5E29701043Q35867432-2A3C0542-ADD3-4751-840A-31C3EAEFE1DCQ35907151-BF6F2376-B169-4316-9B8F-C4AF3FB37D24Q35942909-32DC0F16-EFD2-4B06-97A1-F850F07DF84DQ36133449-506932B4-15AE-4D92-AAF0-CE08770A3934Q36183493-9B682A11-F5D2-4A4D-8651-1B70C00BDBF1Q36332181-1F4D710E-9691-45CF-831A-4C517E6AE557Q36407125-066511F2-09C7-400A-BBCB-05D574ECEB01Q36509823-7F0CE8F0-F024-4EBE-88B4-E58B10FC0873Q36514226-A7064688-FEC5-416F-AD55-C905449F93AA
P2860
Multiple human papillomavirus genotype infections in cervical cancer progression in the study to understand cervical cancer early endpoints and determinants.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
Multiple human papillomavirus ...... ly endpoints and determinants.
@en
Multiple human papillomavirus ...... ly endpoints and determinants.
@nl
type
label
Multiple human papillomavirus ...... ly endpoints and determinants.
@en
Multiple human papillomavirus ...... ly endpoints and determinants.
@nl
prefLabel
Multiple human papillomavirus ...... ly endpoints and determinants.
@en
Multiple human papillomavirus ...... ly endpoints and determinants.
@nl
P2093
P2860
P50
P356
P1476
Multiple human papillomavirus ...... ly endpoints and determinants.
@en
P2093
Joan Walker
Mark E Sherman
Michael A Gold
Richard A Allen
Rosemary E Zuna
Sophia S Wang
Terence Dunn
P2860
P304
P356
10.1002/IJC.24528
P577
2009-11-01T00:00:00Z